Nova Biogenetics, Inc. (IBCL) Sets up Two Subsidiaries: Nova BioPharmaceuticals And Nova Specialty Chemicals 
10/19/2005 5:11:11 PM

Nova BioGenetics (OTC Bulletin Board: NVBG) announces it has formed two private subsidiaries under Nova BioGenetics. The Company elected to make a clear distinction between its Biopharmaceuticals Division and its Specialty Chemicals Division by forming the two subsidiaries. The management of Biopharmaceuticals is headed by Dr. Cecil Smith as Chairman of the Board, Dr. Kevin Smith as CEO, and Mr. Jerry Smith as President. The Specialty Chemicals Division is currently being overseen by Nova BioGenetics' management.